258 related articles for article (PubMed ID: 30645170)
1. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
Singer ES; Ingles J; Semsarian C; Bagnall RD
Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
[TBL] [Abstract][Full Text] [Related]
2. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
[TBL] [Abstract][Full Text] [Related]
3. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
[TBL] [Abstract][Full Text] [Related]
4. Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies.
Frisso G; Detta N; Coppola P; Mazzaccara C; Pricolo MR; D'Onofrio A; Limongelli G; Calabrò R; Salvatore F
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834932
[TBL] [Abstract][Full Text] [Related]
5. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
Suay-Corredera C; Pricolo MR; Herrero-Galán E; Velázquez-Carreras D; Sánchez-Ortiz D; García-Giustiniani D; Delgado J; Galano-Frutos JJ; García-Cebollada H; Vilches S; Domínguez F; Molina MS; Barriales-Villa R; Frisso G; Sancho J; Serrano L; García-Pavía P; Monserrat L; Alegre-Cebollada J
J Biol Chem; 2021 Jul; 297(1):100854. PubMed ID: 34097875
[TBL] [Abstract][Full Text] [Related]
6. Identification of pathogenic gene mutations in
Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in
Holliday M; Singer ES; Ross SB; Lim S; Lal S; Ingles J; Semsarian C; Bagnall RD
Circ Genom Precis Med; 2021 Apr; 14(2):e003202. PubMed ID: 33657327
[TBL] [Abstract][Full Text] [Related]
8. Cryptic Splice-Altering Variants in
Lopes LR; Barbosa P; Torrado M; Quinn E; Merino A; Ochoa JP; Jager J; Futema M; Carmo-Fonseca M; Monserrat L; Syrris P; Elliott PM
Circ Genom Precis Med; 2020 Jun; 13(3):e002905. PubMed ID: 32396390
[No Abstract] [Full Text] [Related]
9. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
[TBL] [Abstract][Full Text] [Related]
10. Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment.
Das K J; Ingles J; Bagnall RD; Semsarian C
Genet Med; 2014 Apr; 16(4):286-93. PubMed ID: 24113344
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of human myosin-binding protein C3 variants associated with hypertrophic cardiomyopathy reveals exon-specific cardiac phenotypes in zebrafish model.
Da'as SI; Yalcin HC; Nasrallah GK; Mohamed IA; Nomikos M; Yacoub MH; Fakhro KA
J Cell Physiol; 2020 Nov; 235(11):7870-7888. PubMed ID: 31943169
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of putative novel splicing mutations in the cardiomyopathy-causing genes.
Millat G; Lafont E; Nony S; Rouvet I; Bozon D
DNA Cell Biol; 2015 Jul; 34(7):489-96. PubMed ID: 25849606
[TBL] [Abstract][Full Text] [Related]
13. ALU transposition induces familial hypertrophic cardiomyopathy.
Nfonsam L; Huang L; Carson N; McGowan-Jordan J; Beaulieu Bergeron M; Goobie S; Conacher S; McCarty D; Benson L; Hewson S; Zahavich L; Sinclair-Bourque E; Smith A; Potter R; Ghani M; Bronicki L; Jarinova O
Mol Genet Genomic Med; 2020 Jan; 8(1):e951. PubMed ID: 31568709
[TBL] [Abstract][Full Text] [Related]
14. Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy.
Saltzman AJ; Mancini-DiNardo D; Li C; Chung WK; Ho CY; Hurst S; Wynn J; Care M; Hamilton RM; Seidman GW; Gorham J; McDonough B; Sparks E; Seidman JG; Seidman CE; Rehm HL
Circ Res; 2010 May; 106(9):1549-52. PubMed ID: 20378854
[TBL] [Abstract][Full Text] [Related]
15. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
Adalsteinsdottir B; Teekakirikul P; Maron BJ; Burke MA; Gudbjartsson DF; Holm H; Stefansson K; DePalma SR; Mazaika E; McDonough B; Danielsen R; Seidman JG; Seidman CE; Gunnarsson GT
Circulation; 2014 Sep; 130(14):1158-67. PubMed ID: 25078086
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
[TBL] [Abstract][Full Text] [Related]
17. Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males.
Méndez I; Fernández AI; Espinosa MÁ; Cuenca S; Lorca R; Rodríguez JF; Tamargo M; García-Montero M; Gómez C; Vilches S; Vázquez N; Álvarez R; Medrano C; Yotti R; Fernández-Avilés F; Bermejo J
Open Heart; 2021 Sep; 8(2):. PubMed ID: 34588271
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.
Erdmann J; Raible J; Maki-Abadi J; Hummel M; Hammann J; Wollnik B; Frantz E; Fleck E; Hetzer R; Regitz-Zagrosek V
J Am Coll Cardiol; 2001 Aug; 38(2):322-30. PubMed ID: 11499719
[TBL] [Abstract][Full Text] [Related]
19. Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree.
Torrado M; Maneiro E; Lamounier Junior A; Fernández-Burriel M; Sánchez Giralt S; Martínez-Carapeto A; Cazón L; Santiago E; Ochoa JP; McKenna WJ; Santomé L; Monserrat L
Sci Rep; 2022 May; 12(1):7284. PubMed ID: 35508642
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
